Skip to main content

Bajaj HealthCare Limited (BAJAJHCARE.BO)

Bombay Stock Exchange (India) Healthcare Drug Manufacturers - Specialty & GenericView data quality →
46.3Fair

ValueMarkers Composite Index

Top 19%#36,154 of 44,707
Overvalued

116% above intrinsic value ($2)

UndervaluedFair ValueOvervalued
Piotroski
4/9
Neutral
Beneish
-0.92
High Risk
Altman
3.42
Safe
DCF Value
$2
Overvalued
ROIC
7.6%
Low
P/E
21.2
Fair
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Bajaj HealthCare Limited (BAJAJHCARE.BO) — VMCI valuation read

Bajaj HealthCare Limited (BAJAJHCARE.BO) carries a VMCI composite of 46/100, 4 points below the Healthcare sector median of 50. Among mid-cap names, that gap places BAJAJHCARE.BO in the bottom third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The BAJAJHCARE.BO insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads BAJAJHCARE.BO trades at 14.0x earnings, 22% below the Healthcare median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Healthcare 12.0x. Quality: ROIC of 18.0% sits 8.0pp above the Healthcare median (10.0%). Risk: net debt to EBITDA of -0.5x leaves covenant headroom, the line to track on Bajaj HealthCare Limited's next 10-Q.

BAJAJHCARE.BO fell 3.2% over the trailing 7 days, with a -3.5% read on a 30-day basis.

Bajaj HealthCare Limited, a pharmaceutical company, research, develops, manufactures, and supplies amino acids, nutritional supplements, and active pharmaceutical ingredients (APIs) for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company's product portfolio consists of various APIs in the therapeutic categories of anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, antihelmintic, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, venous disease, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, lipotropic agents, nootropic, vasoprotective/ antihemorrhagic, cardiovascular agents, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It provides formulations in the form of tablets, capsules, and oral powder, as well as intermediates and impurities. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.

CEO: Sajankumar Rameshwarlal Bajaj1,049 employeesINwww.bajajhealth.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in BAJAJHCARE.BO’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.